Lin BioScience, Inc. (TPEX: 6696)
93.00
+0.10 (0.11%)
Sep 11, 2024, 11:42 AM CST
Lin BioScience Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 1,203 | 3,261 | 1,645 | 806.85 | 1,092 | 117.15 | Upgrade
|
Cash & Short-Term Investments | 4,166 | 3,261 | 1,645 | 806.85 | 1,092 | 117.15 | Upgrade
|
Cash Growth | 113.10% | 98.21% | 103.91% | -26.13% | 832.39% | -56.41% | Upgrade
|
Other Receivables | 0.34 | 25.47 | 0.11 | 1.49 | 0.03 | 0.1 | Upgrade
|
Receivables | 0.34 | 25.47 | 0.11 | 1.49 | 0.03 | 0.1 | Upgrade
|
Other Current Assets | 165.18 | 137.69 | 27.01 | 11.21 | 17.11 | 12.38 | Upgrade
|
Total Current Assets | 4,331 | 3,424 | 1,672 | 819.54 | 1,109 | 129.63 | Upgrade
|
Property, Plant & Equipment | 54.75 | 58.91 | 65.86 | 5.4 | 7.55 | 11.62 | Upgrade
|
Other Intangible Assets | 115.71 | 108.91 | 108.92 | 97.12 | 100.23 | 106.08 | Upgrade
|
Other Long-Term Assets | 5.01 | 4.69 | 4.94 | 1.17 | 1.69 | 1.4 | Upgrade
|
Total Assets | 4,507 | 3,597 | 1,852 | 923.23 | 1,219 | 248.72 | Upgrade
|
Accrued Expenses | 81.27 | 111.47 | 59.16 | 44.94 | 26.39 | 35.38 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 59.95 | Upgrade
|
Current Portion of Leases | 14.77 | 13.85 | 10.32 | 2.24 | 2.91 | 2.83 | Upgrade
|
Other Current Liabilities | 35.4 | 13.38 | 10.39 | 423.07 | 277.33 | 2.66 | Upgrade
|
Total Current Liabilities | 131.43 | 138.7 | 79.88 | 470.25 | 306.63 | 100.81 | Upgrade
|
Long-Term Leases | 22.53 | 29.03 | 36.18 | - | 2.24 | 5.15 | Upgrade
|
Total Liabilities | 153.96 | 167.73 | 116.06 | 470.25 | 308.87 | 105.97 | Upgrade
|
Common Stock | 786.3 | 785.16 | 723.19 | 689.9 | 685 | 595 | Upgrade
|
Additional Paid-In Capital | 4,133 | 3,477 | 1,935 | 1,029 | 952.75 | 125.43 | Upgrade
|
Retained Earnings | -2,509 | -2,162 | -1,475 | -1,162 | -726.93 | -575.08 | Upgrade
|
Comprensive Income & Other | 129.24 | 37.34 | 51.55 | -15.93 | 1.52 | -3.54 | Upgrade
|
Total Common Equity | 2,539 | 2,137 | 1,234 | 541.57 | 912.34 | 141.81 | Upgrade
|
Minority Interest | 1,813 | 1,292 | 501.86 | -88.59 | -2.35 | 0.94 | Upgrade
|
Shareholders' Equity | 4,353 | 3,429 | 1,736 | 452.98 | 909.99 | 142.76 | Upgrade
|
Total Liabilities & Equity | 4,507 | 3,597 | 1,852 | 923.23 | 1,219 | 248.72 | Upgrade
|
Total Debt | 37.3 | 42.87 | 46.5 | 2.24 | 5.15 | 67.94 | Upgrade
|
Net Cash (Debt) | 4,128 | 3,218 | 1,599 | 804.61 | 1,087 | 49.21 | Upgrade
|
Net Cash Growth | 116.73% | 101.30% | 98.70% | -25.99% | 2109.10% | -81.69% | Upgrade
|
Net Cash Per Share | 53.56 | 43.50 | 22.29 | 11.70 | 17.50 | 0.83 | Upgrade
|
Filing Date Shares Outstanding | 78.63 | 78.52 | 72.32 | 68.99 | 68.5 | 59.5 | Upgrade
|
Total Common Shares Outstanding | 78.63 | 78.52 | 72.32 | 68.99 | 68.5 | 59.5 | Upgrade
|
Working Capital | 4,200 | 3,286 | 1,592 | 349.29 | 802.76 | 28.81 | Upgrade
|
Book Value Per Share | 32.29 | 27.22 | 17.07 | 7.85 | 13.32 | 2.38 | Upgrade
|
Tangible Book Value | 2,424 | 2,028 | 1,125 | 444.45 | 812.11 | 35.73 | Upgrade
|
Tangible Book Value Per Share | 30.82 | 25.84 | 15.56 | 6.44 | 11.86 | 0.60 | Upgrade
|
Machinery | 20.87 | 16.64 | 16.44 | 6.04 | 5.9 | 5.9 | Upgrade
|
Leasehold Improvements | 10.99 | 10.67 | 10.67 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.